Tune Therapeutics named Dr. John McHutchison as ... Tune, which has headquarters in Seattle and Durham, N.C., in January announced a $175 million funding round. The biotech company is using ...

Follow along to gain insight into the progress and how this facility will support startups. Durham's Tune Therapeutics To Conduct First Epigenetic Therapy Trial Tune Therapeutics will launch the first ...

The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

A Durham company is aiming to develop innovative treatments for a rare form of blindness. Atsena Therapeutics raises $150 million for gene therapy development. ATSN-201 targets X-linked ...

Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

The JBL Tune 305Cs are an inexpensive way of listening to hi-res audio, thanks to the built-in DAC. They feature an anti-tangle design and a wide soundstage, and most music sounds great through them.

Viking Therapeutics (NASDAQ:VKTX) traded higher in the premarket on Tuesday after the company announced a multi-year production agreement with the contract manufacturer CordenPharma to support the ...

HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...

Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing contract, removing an overhang that has weighed on the stock for ...

PAR2 has emerged as a pivotal therapeutic in inflammatory diseases due to its unique ability to fine-tune immune and inflammatory responses ... Stephan Schann, Chief Scientific Officer of Domain ...

On Tuesday, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is sliding. The company shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with ...